[Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
D002908:Chronic Disease; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D004977:Ethambutol; D012293:Rifampin
Rifampicyna i etambutol w leczeniu codziennym i przerywanym przewlekłej, zaawansowanej jamistej gruźlicy płuc z opornościa na wiele leków. Doniesienie wstepne. Wyniki wczesne.